World's Best Scientists 2026 revealed!
Ulrich Spengler

Ulrich Spengler

D-Index & Metrics

Immunology

D-Index
94
Citations
30114
World Ranking
934
National Ranking
57

Medicine

D-Index
95
Citations
30705
World Ranking
10127
National Ranking
558

Ulrich Spengler publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ulrich Spengler sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 755 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ulrich Spengler D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ulrich Spengler sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 94 D-Index — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ulrich Spengler is affiliated with the University of Bonn in Germany. Their work primarily focuses on Medicine, with a significant emphasis on Hepatology. The scientist's research portfolio includes contributions to several subfields, such as Hepatology, Epidemiology, Immunology, Surgery, and Genetics.

The researcher's main topics of study address various aspects of liver-related diseases and immune system interactions. Key topics include Liver Disease Diagnosis and Treatment, Liver Diseases and Immunity, Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease and Transplantation, Immune Cell Function and Interaction, and HIV Research and Treatment.

Ulrich Spengler has published in multiple notable venues, often contributing to journals focused on liver diseases and related biomedical fields. Frequent publication venues include:

  • Journal of Hepatology
  • Zeitschrift für Gastroenterologie
  • Gastroenterology
  • Frontiers in Medicine
  • The Journal of Infectious Diseases

Some of the recent papers associated with Ulrich Spengler's domain include:

  • A placebo-controlled randomised trial of budesonide for PBC following an insufficient response to UDCA (2020, Journal of Hepatology)
  • Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1 (2020, Gastroenterology)
  • Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization (2022, Immunity)
  • Single-cell RNA sequencing identifies a population of human liver-type ILC1s (2023, Cell Reports)
  • Liver Fibrosis-From Mechanisms of Injury to Modulation of Disease (2022, Frontiers in Medicine)

Ulrich Spengler has collaborated frequently with several co-authors, indicating ongoing scientific partnerships. Notable frequent co-authors include:

  • Christian P. Strassburg
  • Philipp Lutz
  • Bettina Langhans
  • Jacob Nattermann
  • Leona Dold

Best Publications

  • IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

    Vijayaprakash Suppiah;Max Moldovan;Golo Ahlenstiel;Thomas Berg

  • Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

    Vlad Ratziu;Vlad Ratziu;Stephen A. Harrison;Sven Francque;Pierre Bedossa

  • Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production.

    Gerald Messer;Ulrich Spengler;Maria C. Jung;G. Honold

  • Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin.

    Thomas Berg;Michael von Wagner;Samer Nasser;Christoph Sarrazin

  • Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection.

    Naztfa Qurishi;Christina Kreuzberg;Guido Lüchters;Wolfgang Effenberger

  • Long term outcome after transjugular intrahepatic portosystemic stent-shunt in non-transplant cirrhotics with hepatorenal syndrome: a phase II study

    K A Brensing;J Textor;J Perz;P Schiedermaier

  • Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo‐controlled trial

    Ulrich Beuers;Ulrich Spengler;Wolfgang Kruis;ülker Aydemir

  • Budesonide induces remission more effectively than prednisone in a controlled trial of patients with autoimmune hepatitis

    Michael P. Manns;Marek Woynarowski;Wolfgang Kreisel;Yoav Lurie

  • NATURALLY OCCURRING DOMINANT RESISTANCE MUTATIONS TO HEPATITIS C VIRUS PROTEASE AND POLYMERASE INHIBITORS IN TREATMENT-NAIVE PATIENTS

    Thomas Kuntzen;Joerg Timm;Andrew Berical;Niall Lennon

  • A Polymorphism Near IL28B Is Associated With Spontaneous Clearance of Acute Hepatitis C Virus and Jaundice

    Hans L. Tillmann;Alex J. Thompson;Keyur Patel;Manfred Wiese

  • Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues†

    Florian van Bömmel;Robert A. de Man;Heiner Wedemeyer;Katja Deterding

  • Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.

    Florian van Bömmel;Bernhard Zöllner;Christoph Sarrazin;Ulrich Spengler

  • Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience

    H. L. Tillmann;J. Hadem;L. Leifeld;K. Zachou

  • Bleeding complications after percutaneous liver biopsy. An analysis of risk factors.

    Birgit Terjung;Isabelle Lemnitzer;Franz Ludwig Dumoulin;Wolfgang Effenberger

  • Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C

    Jacob Nattermann;Georg Feldmann;Golo Ahlenstiel;Bettina Langhans

  • norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis

    Peter Fickert;Gideon M Hirschfield;Gerald Denk;Hanns-Ulrich Marschall

  • Tumor necrosis factor α in the pathogenesis of human and murine fulminant hepatic failure

    Konrad Streetz;Ludger Leifeld;Danja Grundmann;Jan Ramakers

  • Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta‐analysis of individual participant data

    Eric Trepo;Pierre Nahon;Pierre Nahon;Gianluca Bontempi;Luca Valenti

  • HIV and hepatitis C virus co-infection

    Jürgen Kurt Rockstroh;Ulrich Spengler

  • Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B

    M.-C. Jung;U. Spengler;W. Schraut;R. Hoffmann

  • Daclatasvir plus sofosbuvir, with or without ribavirin, achieved high sustained virological response rates in patients with HCV infection and advanced liver disease in a real-world cohort

    Tania Mara Welzel;Jörg Petersen;Kerstin Herzer;Peter Ferenci

Frequent Co-Authors

Tilman Sauerbruch
Tilman Sauerbruch University of Bonn
Jacob Nattermann
Jacob Nattermann University Hospital Bonn
Christian P. Strassburg
Christian P. Strassburg University Hospital Bonn
Jürgen K. Rockstroh
Jürgen K. Rockstroh University Hospital Bonn
Jonel Trebicka
Jonel Trebicka University Hospital of Münster
Johannes Oldenburg
Johannes Oldenburg University of Bonn
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Gerd R. Pape
Gerd R. Pape Ludwig-Maximilians-Universität München
Frank Lammert
Frank Lammert Saarland University
Stefan Mauss
Stefan Mauss Université Paris Cité

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Nursing professionals, in particular, can benefit from specialized programs that enhance their scope of practice and salary potential. For example, understanding dnp salary by specialty offers insights into how advanced degrees impact earnings and career growth.

Many registered nurses look to transition from a Family Nurse Practitioner (FNP) role to an Acute Care Nurse Practitioner (ACNP) to handle more critical patient care responsibilities. Guidance on this move can be found in resources like fnp to acnp, which details the education and certification requirements involved.

Accredited programs that accelerate nursing education are vital for those pursuing faster entry into practice. The best accelerated nurse practitioner online programs, highlighted at accelerated fnp programs, make it possible to efficiently earn advanced degrees while balancing other responsibilities.

For individuals without a nursing background, online programs tailored for non-nurses can be an excellent starting point. The online absn programs for non nurses provide structured pathways to quickly obtain nursing degrees, opening doors to immunology-related clinical roles and research careers.

Best Scientists Citing Ulrich Spengler

Trending Scientists

Recently Published Articles